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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S226management of CPSP as difﬁcult, and there was a tension between their
desire to help patients and the concern that keeping patients ‘in the
system’ of secondary care might not always be helpful. Identifying ways
to improve services, participants described specialist services, speciﬁ-
cally multidisciplinary pain clinics and pain management programmes,
as having a vital and speciﬁc role in helping patients with CPSP.
Conclusion: Despite healthcare professionals’ commitment to helping
patients with CPSP, coherent referral pathways and services to manage
CPSP were described as lacking, resulting in an unsatisfactory approach.
By corollary, better services would provide a joined up pathway that
would assist patients and healthcare professionals involved in their
care. This small-scale study complements ongoing work that highlights
the diversity of services for CPSP after knee replacement across the UK,
in which some examples of clear pathways are apparent. Future
research is needed to assess the impact of clear referral pathways and
integrated service provision for patients with CPSP after total knee
replacement.
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QUADRICEPS MUSCLE STRENGTH AND ITS RELATIONSHIP TO
RADIOGRAPHIC KNEE OSTEOARTHRITIS
S. Takagi. Nagaoka Chuo General Hosp., Nagaoka, Japan
Purpose: Knee osteoarthritis (OA) is a multifactorial disease and
strongly affected by mechanical factors.
The aim of the present study was to evaluate the relationship between
quadriceps strength measured by the Quadriceps Training Machine
(QTM) (QTM-05F, Alcare Co., Ltd. Tokyo, Japan) and radiographic knee
OA by epidemiological survey.
Methods: The relationship between radiographic knee OA and quad-
riceps strength was investigated with 1,112 knees in 556 subjects by
epidemiological survey. They were inhabitants in the Matsudai district
in Niigata prefecture and they all participated in an extensive survey of
knee OA in 2013 (Matsudai knee Osteoarthritis Survey). Bilateral
quadriceps strength of each subject was measured by the QTM. Meas-
ured value was divided by body weight and we evaluated this data as
muscle strength per body weight ratio (M/P ratio). Furthermore, a
weight-bearing standing knee radiograph was obtained and graded
according to the Kellgren–Lawrence classiﬁcation. Radiographic knee
OA was deﬁned if a Kellgren–Lawrence grade of II or higher was
detected. From these results, the change in quadriceps muscle strength
level by gender and by age, comparison of the quadriceps muscle
strength level between the non-OA group and OA group, and the change
in quadriceps muscle strength level by gender and by knee OA grades,
were investigated.
Results: In the Matsudai Knee Osteoarthritis Survey, the prevalence of
radiographic OA (grade II or higher upon Kellgren-Lawrence classi-
ﬁcation) was: 10.9, 39.6, 64.6, and 84.1%, regarding women in their
ﬁfties, sixties, seventies, and eighties, and was: 9.5, 13.8, 37.3, and 53.8%
regarding men, respectively. Quadriceps muscle strength declined fol-
lowing 60 years of age in women, and signiﬁcant decline was observed
in their seventies and eighties. Quadriceps muscle strength of the OA
group (grades II, III and IV) was signiﬁcantly declined compared with
that of the Non-OA group (grade 0 and I). Furthermore, the tendency of
the muscle strength level to decline with the progression of knee OA
grade was particularly observed between grade I and grade II in both
men and women.
Conclusions: The relationship between radiographic knee OA and
quadriceps strength was quantitatively evaluated by an epidemiological
survey (Matsudai knee Osteoarthritis Survey in 2013), and we found a
correlation between knee OA and the decline in quadriceps strength.
Furthermore, it was suggested that the decline in quadriceps muscle
strength may be more strongly related to the incidence of the knee OA
than to its progression. We have conducted the extensive survey of knee
OA (Matsudai knee Osteoarthritis Survey) since 1979, and quadriceps
muscle strength was measured by the QTM every three years since
2010. We believe that longitudinal analyzing the same cohorts and
investigating whether or not a decrease in quadriceps muscle strength
is the cause of incidence or progression of knee OA in addition to
conducting the same investigation regarding symptomatic knee OA are
necessary.Genetics and Genomics and Epigenetics
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A GAIN OF FUNCTION MUTATION IN TNFRSF11B CAUSES
OSTEOARTHRITIS WITH CHONDROCALCINOSIS
Y.F. Ramos y,z, S.D. Bos y,z, R. van der Breggen y, J. Deelen y,z,
M. Kloppenburg y, K. Ye y, M. Beekman y,z, E.-W.E. Lameijer y,
R.G. Nelissen y, P.E. Slagboom y,z, I. Meulenbelt y,z. y Leiden Univ. Med.
Ctr., Leiden, Netherlands; zNetherlands Consortium for Hlth.y Ageing,
Leiden-Rotterdam, Netherlands
Purpose: Osteoarthritis (OA) is the most common arthritic disease and
a leading cause of disability among elderly. Developing new therapies to
slow down or cure OA requires deeper insight into underlying biological
mechanisms driving OA. We hypothesized that next generation
sequencing using OA patients with a familial history of OA can con-
tribute to the identiﬁcation of causal pathogenic mutations leading to
more general pathways in which other genetic variations may affect
susceptibility to common OA.
Methods: Exome sequencing was applied to two distant family mem-
bers with dominantly inherited early onset primary OA at multiple joint
sites characterized by chondrocalcinosis. By applying an eligible pri-
oritization scheme ﬁve candidates were selected for de novo genotyping
and linkage analysis across the extended family. The effect of the
mutation was investigated by means of a cell-based assay and to
investigate generalizability of the genes that act in the identiﬁed
pathway, expression analyses was performed in preserved and osteo-
arthritic cartilage of 33 independent patients.
Results: Exome sequencing of the 2 individuals with familial early onset
OA (FOA) identiﬁed 57,018 and 60,652 variants, respectively. The het-
erozygous, read-through mutation (c.1205A¼>T;p.Stop402Leu) in
TNFRSF11B encoding osteoprotegerin (OPG) showed complete co-seg-
regation with the OA phenotype (LOD-score 3.48) and is, therefore,
likely causal to the disease in this family. The mutation was absent in
1,467 independent OA affected subjects and 744 random controls
indicating that it may be private for this family. OPG is a soluble decoy
receptor which inhibits osteoclastogenesis by competing with the
receptor activator of the nuclear factor-KB (RANK, encoded by
TNFRSF11A), expressed on the membrane of pre-osteoclasts, for the
binding of the nuclear factor-KB ligand (RANKL, encoded by TNFSF11).
The mutant OPG protein showed enhanced capacity to inhibit osteo-
clastogenesis and concurrent bone resorption (P-value <0.05), indi-
cating a gain of function mutation. Expression analyses in preserved
and osteoarthritic cartilage indicated that up-regulation of the
TNFRSF11B/TNFSF11 ratio (1.1-fold, P ¼ 2.0  104) is a general phe-
nomenon in the pathophysiological OA process.
Conclusions: We are the ﬁrst to demonstrate that enhanced OPG
function towards matrix mineralization could be directly causal to the
onset of OA. Even more, the gene expression pattern indicated that
enhanced OPG-mediated antagonism could be a more general phe-
nomenon in the pathophysiological process of OA. These ﬁndings and
extensive literature showing high systemic bone mass as a consistent
OA risk factor are in contrast to recent studies reporting on beneﬁcial
effects of anti-osteoporotic drugs in OA patients. We strongly recom-
mend investigation of long term effects of these bone forming therapies
in OA and advocate that agents counteracting the function of OPG could
comply with development of new disease modifying treatments in OA.
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DISCOVERY AND ANALYSIS OF RARE CODING VARIANTS FOR HIPOA
BY EXOME-SEQUENCING
C.G. Boer, J.v. Rooij, M. Peters, R. Kraaij, M. Jhamai, P. Arp,
A. Uitterlinden, J.v. Meurs. Erasmus Med. Ctr., Rotterdam, Netherlands
Purpose: It is well established that Osteoarthritis (OA) is to a large
extend genetically determined. Over the last years several GWAS
studies have identiﬁed multiple genetic loci associated with OA. How-
ever, only a small proportion of the heritability is explained by these
loci. It is anticipated that a part of the unexplained variancemust be due
to rare variants, possibly unique to the disease under study. These rare
variants are missed in a common GWAS study, where only common
variants are examined. We here present the ﬁrst exome-sequencing
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S227results done for OA. We focus our analysis on the exome, since variants
in the protein-coding part of the genome are more likely to have a
functional consequence.
Methods: The Rotterdam study is a large prospective study population
of over 15.000 individuals ages 45 years and older all living in the
Ommoord district of Rotterdam in the Netherlands. The ﬁrst partic-
ipants were recruited in 1990, and 4 follow-up visits have been done so
far, while continuous monitoring through general practitioners and
pharmacies is also in place. All of the participants were deeply phe-
notyped for osteoarthritis by radiographs and questionnaires. For 1,524
participants, whole exome-sequencing has been performed at a mean
coverage of 40x per base. This allows to ﬁnd novel rare variants, not
identiﬁed previously. We aim to identify functional variants associated
with hipOA and its endophenotype, minimal joint space width (mJSW)
a proxy for cartilage thickness in the hip joint. Our approach included a
candidate gene approach for all genes previously found associated with
hipOA. In addition, we conducted exome-wide association analysis on
all variants found (199 cases, Kellgren-Lawrence grading 2; 1337
Table 1
Variants found in OA candidate genes in the Rotterdam Study – 1 cohort
Candidate OA gene Variants Singletons Synonymous Nonsynonymous Intronic
ASTN2 77 49 11 12 5
DIO2 18 13 4 1 0
DOT1L 117 89 7 8 13
FGFR3 72 47 11 4 10
FILIP1 41 27 6 7 1
GLT8D1 16 14 1 0 1
GNL3 25 18 22 3 2
MCF2L 126 86 16 14 10
NCOA3 122 107 4 8 3
PIK3R1 2 1 0 1 0
PTHLH 13 12 0 0 1
RUNX2 14 12 1 3 1
SENP6 118 101 3 9 5
Table 2
Variants associated to mJSW and hipOA in the Rotterdam Study – I cohort
A. Single-variant analysis
Discovery
Variant Chr Position Reference allele Variant allele Gene Type Phenotype Frequency SE P N
rs3U5898yz 4 1807922 G A FGFR3 Intronic mJSW 0.0099 0.1896 4.92E-06 1006
rs138836456 9 119568036 G A ASTN2 Synonymous mJSW 0.0027 0.3435 5.01E-03 1097
rs114754024yz 4 1806044 C T FGFR3 Intronic hipOA* 0.0083 0.5006 7.90E-03 1082
*Kellgren-Lawrence Grading 2
ySome intronic/intergenic regions are present in exome-sequencing data
zVariants not in linkage disequilibrium r2 < 0.1
B. Candidate gene Burden test
Gene Chr Position Variants Phenotype P
FGFR3 4 1801219 – 1807922 17 mJSW/HipOA* 8.68E-05
TFGa 2 70677994 – 70677994 1 mJSW 0.00786678
NCOA3 20 46256424 - 46280031 9 HipOA 0.0163782
*Kellgren-Lawrence Grading 2controls) and mJSW (minimal cartilage thickness in mm) as the phe-
notypes of interest.
Results: We analyzed in total 199 hipOA cases and 1337 controls,
while we had in total 1242 individuals available with data for mJSW.
To investigate if other coding variants associated to hipOA and mJSW
might be located in the previously identiﬁed hipOA genes, we ana-
lyzed a group of 13 candidate genes in our exome sequencing data
(see table 1). This list includes also 3 genes we identiﬁed to be
associated to mJSW with a GWAS meta-analysis (FGFR3, RUNX2, and
TGFa). We identiﬁed 761 variants in these genes, from which the
majority was found only once (576 singletons). Of the remaining
variants, 70 were non-synonymous, 86 synonymous and 52 intronic;
these variants (excluding the singletons) were analyzed further. Wenext performed gene-based rare-variant tests on these hipOA genes,
by comparing the burden, i.e. amount of rare variants, in OA cases
compared to controls. In 3 candidate genes a nominal signiﬁcant hit
was found (FGFR3, TGFa and NCOA3), after Bonferroni correction
only FGFR3(p ¼ 8.68E-05) remained highly signiﬁcant. The single-
variant analysis yielded 3 signals with a strong association to the
mJSW or hipOA in the exome sequencing data set (p < 10E-2, see
table 2A). The strongest signal for mJSW was a rare variant in the
FGF3 gene, the same gene also identiﬁed in the gene speciﬁc burden
test. This rare variant was not associated to the GWAS signal iden-
tiﬁed before by us (r2 < 0.1). FGFR3 has previously been shown to
be involved in endochondral bone formation. In addition, mutations
in FGFR3 result in achondroplasia.
Conclusions: We identiﬁed rare variants in the FGF3 gene to be asso-
ciated with extreme values of mJSW. Currently we are working on
replication of these ﬁndings. Future analysis will consist of further
functional assessment of the identiﬁed variants.405
EXPRESSION PROFILING OF SUBCHONDRAL BONE IN
OSTEOARTHRITIS KNEE JOINT TISSUE
M. Lee y,z, C-H. Chou x, C-C. Wu k. yCtr. for Integrative Med. Sci., RIKEN,
Yokohama, Japan; z Inst. of BioMed. Sci., Academia Sinica, Taipei,
Taiwan; xDuke Univ. Med. Ctr., Durham, NC, USA; k Tri-Service Gen.
Hosp., Natl. Defense Med. Ctr., Taipei, Taiwan
Purpose: Osteoarthritis (OA) is a disease of the whole joint organ
involving pathological changes of articular cartilage (AC), structural
changes of underlying subchondral bone (SB) and synovitis. Many
studies utilizing expression array chip technology have been performed
on AC, however, very few has been performed on the SB. We have
